Award
NIH Reporter #1F31AI200226-01
Developing Prodrugs to Selectively Suppress Beta-lactam Resistant Bacteria
Recipient
Duke University
Award Amount
$43,625.00
Ceiling
$43,625.00
Awarded
May 25, 2026
Identifier
1F31AI200226-01
Award for developing β-lactam prodrugs to selectively target resistant bacteria, preserving beneficial microbiota.
Description
This project focuses on developing β-lactam prodrugs that are selectively activated by β-lactamases in resistant bacteria, aiming to combat antibiotic resistance while preserving beneficial microbiota.